Sanofi was founded in 2004 as a result of merger of two companies - Aventis and Sanofi-Synthélabo.
Image: company logo
Initially the merger was opposed by Aventis but later the negotiations were made and bidding value was increased to 54.5 billion Euros from 47.8 billion Euros. Earlier it was known as Sanofi-Aventis which was changed to Sanofi in 2011.
The headquarter of the company is situated in Gentilly, France. Jean-François Dehecq was the founder of the company. Serge Weinberg serves as the Chairman of Sanofi while Olivier Brandicourt is the CEO of the company. Firm is active mainly in prescription sales. More than 1.2 lakh people are employed at Sanofi. Sanofi has approximately 400 subsidiaries of which 14 are the most important subsidiaries.
The activities of Sanofi revolve around three activities –
Sanofi has a dedicated Animal Health division known as Merial. Sanofi is divided into four global business units - General Medicines & Emerging Markets, Specialty Care, Diabetes & Cardiovascular, Sanofi Pasteur and Merial. Most important pharmaceutical products of the company are - diabetes, cardiovascular disease, rare diseases, multiple sclerosis and oncology.
The company had a revenue of $ 39265.45 million in 2015. Its total profits were $ 4873.23 million. The market capitalization of the company was at $ 114850 million.